Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the Intussusception market right now?

The market size for intussusception has seen robust growth lately. The market is projected to expand from $4.45 billion in 2024 to a higher value of $4.69 billion in 2025, with a compound annual growth rate (CAGR) pegged at 5.3%. The growth experienced in the recent past is attributable to several factors including improved methodologies for diagnosis, increased public awareness and educational initiatives, developments in global healthcare infrastructure, investments in research and development initiatives, as well as increased collaborations among healthcare organizations.

How fast Is the intussusception market expected to grow, and what’s its future value?

Expectations are high for consistent growth in the intussusception market in the upcoming years. With a projected compound annual growth rate of 4.1%, the market is slated to reach a size of $5.52 billion by 2029. This growth trajectory during the forecast period is largely ascribed to a few key factors including ongoing medical education initiatives, child immunisation programs, international efforts in child healthcare, concentration on post-surgical care and an increasing demand for research in paediatric gastroenterology, along with telemedicine and remote medical assistance. The forecast period will also witness significant trends such as progress in diagnostic imaging, the emergence of less invasive treatment modalities, the creation of child-specific interventions, studies on the causes and risk factors, worldwide epidemiological studies, the execution of immunisation programs and the implementation of telemedicine in diagnosis and consultation.

Get your intussusception market report here!

https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

What are the leading drivers of growth in the intussusception market?

The progression of the intussusception market is expected to be driven by the growing prevalence of intestinal disorders. Intestinal disorders, which refer to any medical problem that hampers the normal operation of the intestines, could lead to an early detection, better treatment options, and increased support for those suffering from intussusception, thus improving their health and overall quality of life. Intestines play a vital function in nutrient absorption and waste elimination, part of the human digestive system. The American Cancer Society (ACS), a US health organization aimed at ending cancer, highlighted that gastrointestinal cancers surged by 3.18% to 348,840 in January 2023, up from 338,090 in 2021 in the United States. Thus, the escalating prevalence of intestinal disorders is projected to fortify the advancement of the intussusception market. The burgeoning intussusception market is being boosted by growing healthcare expenditure. Healthcare spending involves the total financial resources dedicated to the healthcare industry within a specific location, country, or institution and is directed towards meeting medical requirements. The existence of conditions like intussusception calls for medical interventions, diagnostic procedures, and potential surgical treatments, which subsequently increase healthcare spending. For instance, the Canadian Institute for Health Information suggested that in 2023, the total healthcare expenditure in Canada is predicted to hit $344 billion, amounting to $8,740 per individual. This depicts a 2.8% rise from the previous year, which reported only a 1.5% increment in health spending in 2022, revealing a significant resurgence in healthcare funding. Therefore, the escalating healthcare expenditure is fueling the growth of the intussusception market.

What are the key segments defining the intussusception market?

The intussusception market covered in this report is segmented –

1) By Type: Idiopathic Intussusception, Secondary Intussusception

2) By Treatment: Enema Reduction, Surgery, Other Treatment

3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)

4) By End-User: Hospitals, Clinics, Other End-User

Subsegments:

1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception

2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical Intussusception

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

Who are the key players steering the development of the intussusception market?

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

What emerging trends are influencing the growth of the intussusception market?

Key players within the intestinal pseudo-obstruction treatment market are pioneering new drug remedies like the NHE3 inhibitor treatment therapy for the benefit of their consumers. This particular mode of treatment acts upon the Sodium-Proton-Exchanger subtype 3 (NHE3) found in the digestive tract. In line with this, Ardelyx Inc., a biopharmaceutical establishment from the United States, brought IBSRELA into the market in April 2022. This medication, an NHE3 inhibitor, targets irritable bowel syndrome accompanied by constipation (IBS-C) among adult patients and can enhance gastrointestinal mobility. The functioning of IBSRELA treatment therapy revolves around restraining or countering the operation of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The drug’s approval nodded to data derived from two Phase 3 clinical tests involving more than 1,200 IBS-C patients. Evidence suggested IBSRELA not only minimised abdominal discomfort and optimised bowel activities – reaching the primary endpoint – but also showed results as early as the first week, maintaining these positive effects over a stretch of 26 weeks in the extended trial.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

Which regions are most influential in expanding the intussusception market?

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Tracheitis Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tracheitis-treatment-global-market-report

Pharyngitis Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

Onychomycosis Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: